Using genetic data to find protein targets for type 2 diabetes
Part of Hormones & metabolism clinical trials.
This study looks at existing health and genetic data from people aged 40 to 84 to find new protein targets that might help treat type 2 diabetes. No new participants are needed, and researchers will analyze data from previous studies.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 40 and 84 years old
- You have type 2 diabetes or are at risk for it
- Your genetic and blood protein data are available from previous research studies
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This is a screening study to identify and understand people with type 2 diabetes whose blood sugar isn't well controlled, so they can potentially join future diabetes research trials. You won't receive a new treatment in this study—it's about getting to know your health history and seeing if you might be a good fit for upcoming studies.
This study looks at how genetic risk relates to developing type 2 diabetes, using information from a biobank and body measurements like weight. It may help researchers better identify who is at higher risk before diabetes starts.
This trial is studying people with certain types of diabetes, including diabetes that starts after age 30 or in pregnancy, to help improve clinical care. You may be invited if your diabetes type fits the study’s genetic and antibody criteria.
This study looks at people with type 2 diabetes to understand their health. If you join, you'll have simple measurements taken like height, weight, and grip strength.
This study looks at genetic factors in people recently diagnosed with diabetes to understand what might predict who needs insulin treatment. Researchers will analyze blood samples and medical information to see if genetic testing could help doctors predict your treatment path.
This study uses genetic information from a biobank to find adults who may be at risk for type 1 diabetes before symptoms appear. It may help identify early stages of the disease, so monitoring or prevention can begin sooner.
Hear when a new Type 2 Diabetes Mellitus (DM) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.